Mustang Bio, Inc. (MBIO)
USD 0.17
(-5.14%)
USD 0.17
(-5.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -49.47 Million | -65.06 Million | -53.66 Million | -37.31 Million | -33.58 Million | -19.24 Million |
| Net Income | -51.6 Million | -77.52 Million | -66.37 Million | -60.01 Million | -46.38 Million | -30.66 Million |
| Depreciation & Amortization | 2.22 Million | 3.03 Million | 2.3 Million | 1.78 Million | 1.36 Million | 630 Thousand |
| Deferred income taxes | -125 Thousand | - | - | - | - | - |
| Stock-based compensation | 568 Thousand | 2.28 Million | 3.3 Million | 2.98 Million | 2.66 Million | 4.96 Million |
| Change in working capital | -2.97 Million | 4.03 Million | -637 Thousand | 3.09 Million | 132 Thousand | 2.46 Million |
| Other non-cash items | 2.43 Million | 3.11 Million | 7.72 Million | 14.83 Million | 8.64 Million | 3.36 Million |
| Investing Cash Flow | 5.88 Million | -2.95 Million | -5.36 Million | -4.41 Million | 13.9 Million | 557 Thousand |
| Investments in PPE | -114 Thousand | -3.07 Million | -5.36 Million | -4.41 Million | -3.69 Million | -7.94 Million |
| Acquisitions | 6 Million | 127 Thousand | - | - | - | 1.07 Million |
| Investment purchases | - | - | - | - | - | -52.5 Million |
| Sales/Maturities of investments | - | - | - | - | 17.6 Million | 61 Million |
| Other Investing Activities | 5.95 Million | -238 Thousand | -1.38 Million | -2.48 Million | 16.25 Million | -1.07 Million |
| Financing Cash Flow | -26.08 Million | 34.05 Million | 70.84 Million | 78.12 Million | 65.11 Million | 181 Thousand |
| Debt repayment | -30.37 Million | -27.35 Million | - | -15.75 Million | -13.6 Million | - |
| Dividends payments | -477 Thousand | - | - | - | - | - |
| Common Stock Repurchased | 923 Thousand | - | - | - | - | - |
| Common Stock Issuance | 4.29 Million | 6.62 Million | 71.91 Million | 97.03 Million | 54.14 Million | 181 Thousand |
| Other Financing Activities | -922 Thousand | 54.78 Million | -1.07 Million | -3.16 Million | 24.58 Million | 181 Thousand |
| Accounts receivables | -3.58 Million | 14 Thousand | -35 Thousand | 4000.00 | -19 Thousand | -35 Thousand |
| Accounts payables | 125 Thousand | 5.3 Million | -175 Thousand | 3.15 Million | 296 Thousand | 2.47 Million |
| Inventory | - | -14 Thousand | 35 Thousand | -4000.00 | 19 Thousand | - |
| Other working capital | 479 Thousand | -1.27 Million | -462 Thousand | -58 Thousand | -164 Thousand | -2000.00 |
| Cash at beginning of period | 75.65 Million | 110.61 Million | 98.8 Million | 62.41 Million | 16.96 Million | 35.47 Million |
| Cash at end of period | 6.23 Million | 76.65 Million | 110.61 Million | 98.8 Million | 62.41 Million | 16.96 Million |
| Capital Expenditure | -114 Thousand | -3.07 Million | -5.36 Million | -4.41 Million | -3.69 Million | -7.94 Million |
| Effect of forex changes on cash | -1000.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -69.42 Million | -33.96 Million | 11.81 Million | 36.39 Million | 45.44 Million | -18.5 Million |
| Free Cash Flow | -49.59 Million | -68.14 Million | -59.03 Million | -41.73 Million | -37.27 Million | -27.18 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.19 Million | -5.19 Million | -51.6 Million | -8.61 Million | -10.05 Million | -16.23 Million |
| Depreciation & Amortization | 300 Thousand | 696 Thousand | 2.22 Million | 363 Thousand | 367 Thousand | 637 Thousand |
| Deferred income taxes | - | - | -125 Thousand | -3.1 Million | -1.35 Million | 2.79 Million |
| Stock-based compensation | -618 Thousand | 76 Thousand | 568 Thousand | 188 Thousand | 100 Thousand | 45 Thousand |
| Change in working capital | 3.95 Million | -902 Thousand | -2.97 Million | -101 Thousand | -1.13 Million | 610 Thousand |
| Other non-cash items | -800 Thousand | 3.33 Million | 2.43 Million | 4.01 Million | 53 Thousand | -245 Thousand |
| Investing Cash Flow | - | - | 5.88 Million | -30 Thousand | 5.95 Million | -34 Thousand |
| Investments in PPE | - | - | -114 Thousand | -30 Thousand | -50 Thousand | -34 Thousand |
| Acquisitions | - | - | 6 Million | -6 Million | 6 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 5.95 Million | 5.95 Million | - | - |
| Financing Cash Flow | 5.26 Million | 49 Thousand | -26.08 Million | 3.95 Million | 250 Thousand | -30.28 Million |
| Debt repayment | - | - | -30.37 Million | -30.37 Million | - | -30.37 Million |
| Dividends payments | - | - | -477 Thousand | -477 Thousand | - | - |
| Common Stock Repurchased | - | - | 923 Thousand | - | - | - |
| Common Stock Issuance | 5.26 Million | 49 Thousand | 4.29 Million | 3.95 Million | 163 Thousand | 88 Thousand |
| Other Financing Activities | 5.26 Million | 49 Thousand | -922 Thousand | 1000.00 | 87 Thousand | - |
| Accounts receivables | 3.02 Million | -2.85 Million | -3.58 Million | -3.61 Million | - | - |
| Accounts payables | -16 Thousand | 997 Thousand | 125 Thousand | 1.42 Million | 723 Thousand | 289 Thousand |
| Inventory | - | - | - | 2.38 Million | - | - |
| Other working capital | 944 Thousand | 960 Thousand | 479 Thousand | 2.09 Million | -1.85 Million | 321 Thousand |
| Cash at beginning of period | 1.33 Million | 6.23 Million | 75.65 Million | 9.56 Million | 16.13 Million | 58.84 Million |
| Cash at end of period | 4.26 Million | 1.33 Million | 6.23 Million | 6.23 Million | 10.31 Million | 16.13 Million |
| Capital Expenditure | - | - | -114 Thousand | -30 Thousand | -50 Thousand | -34 Thousand |
| Effect of forex changes on cash | - | - | -1000.00 | -1000.00 | 5.92 Million | 42.75 Million |
| Net cash flow / Change in cash | 2.93 Million | -4.89 Million | -69.42 Million | -3.32 Million | -5.82 Million | -42.71 Million |
| Free Cash Flow | -2.33 Million | -5.32 Million | -49.59 Million | -7.28 Million | -12.07 Million | -12.42 Million |
TBNGY
NEELKAN
ODP
DC
1203
4769